These compounds may interact with:
5-hydroxytryptamine receptor 2B
Potentially involved in: carcinoma; migraine; heart disease; irritable bowel syndrome; hypertension; schizophrenia; hypoactive sexual desire disorder; obesity; cardiomegaly; heart failure; heart valve disease; hypertensive disease; pulmonary hypertension; adverse reaction to drug; adrenocortical carcinoma; invasive ductal carcinoma; malignant mesothelioma; non diabetic and post-ischemic heart failure; osteosarcoma; psoriasis
Disease data sourced from Pharos.